THE INCREASE OF CELLULAR ANTIOXIDANT ENZYMES ACTIVITY BY METABOLIC DRUG ELTACIN IN THERAPY OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE ArticleKalinina E., Zaslavskaya R., Nartsissov Y.Cardiology. Том 140. 2018. С. 402-402
ANTIOXIDANT EFFECT OF ELTACIN IN THERAPY OF PATIENTS WITH ISCHEMIC HEART DISEASE ArticleKalinina E.V., Zaslavskaya R.M., Nartsissov Y.R.Cardiology. Том 137. 2017. С. 316-316
REGULATION OF REDOX-HOMEOSTASIS BY METABOLIC DRUG ELTACIN IN THERAPY OF AGING PATIENTS WITH ISCHEMIC HEART DISEASE ArticleKalinina E.V., Zaslavskaya R.M., Nartsissov Y.R.Cardiology. Том 134. 2016. С. 434-434
DURATION OF DUAL ANTIPLATELET THERAPY IN RUSSIAN PATIENTS AFTER MYOCARDIAL INFARCTION (EPICOR-RUS STUDY) ArticleKhomitskaya Y., Ruda M., Averkov O., Apanova O.Cardiology. Том 132. 2015. С. 196-197
ANTIPLATELET THERAPY PATTERNS IN NON ST-ELEVATION MYOCARDIAL INFARCTION IN URBAN RUSSIA (EPICOR-RUS STUDY) ArticleRuda M., Averkov O., Apanova O., Khomitskaya Y.Cardiology. Том 132. 2015. С. 198-198
ANTIOXIDANT EFFECT OF METABOLIC DRUG ELTACIN AND ITS USE IN THERAPY OF AGING PATIENTS WITH ISCHEMIC HEART DISEASE ArticleKalinina E.V., Zaslavskaya R.M., Nartsissov Y.R.Cardiology. Том 128. 2014. С. 481-481